Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage yes

Stroke

Volumn 42, Issue 12, 2011, Pages 3661-3662

  Steiner, Thorsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Anticoagulation; Hemorrah; Intrac; Intracerebral hemorrhage; Prevention; Risk factors; Therapy

Indexed keywords

DABIGATRAN; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD PRESSURE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LIPID METABOLISM; LIVER DYSFUNCTION; NOTE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STROKE; THROMBOSIS PREVENTION;

ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DRUG ADMINISTRATION SCHEDULE; HUMANS; STROKE; WARFARIN;

EID: 84856229018     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.621797     Document Type: Note

References (7)

1. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.
2. Majeed A, Kim YK, Roberts RS, Holmstrom M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41:2860-2866.
3. Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol. 1998;103:1064-1066. (Pubitemid 29012644)
4. Olesen JB, Lip GY, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, et al. Bleeding risk in 'real world' patients with atrial fibrillation: Comparison of two established bleeding prediction schemes in a nationwide cohort. J Thromb Haemost. 2011;9:1460-1467.
5. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000;342:240-245. (Pubitemid 30058955)
6. Romualdi E, Micieli E, Ageno W, Squizzato A. Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review. Thromb Haemost. 2009;101:290-297.
7. Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010;376:975-983.